何建媚
HE Jianmei

• 1:河北钢铁集团宣化钢铁公司职工医院

摘要(Abstract)：

目的:探讨冠状动脉心脏病(CHD)合并糖尿病(DM)患者血清淀粉样蛋白A(SAA)及C反应蛋白(CRP)的表达。方法:选取经冠状动脉造影术(CAG)确诊为CHD的患者100例,其中合并DM患者42例为A组,单纯CHD患者58例为B组,同期经CAG排除CHD的患者30例为对照组,用双抗体夹心酶联免疫吸附试验(ELISA)测定血清SAA水平,速率散射比浊法测定CRP水平,并与冠脉Gensini评分进行相关性分析。结果:A组患者血清SAA明显高于B组及对照组,A、B组血清CRP水平显著高于对照组,差异有统计学意义(P<0.05);A、B组血清CRP水平比较,差异无统计学差异(P>0.05);SAA与冠脉Gensini评分呈正相关(r=0.738,P<0.05),SAA与CRP两者呈成正相关性(r=0.815,P<0.05)。结论:SAA、CRP对CHD合并DM的病情及其预后具有一定的预测价值。
Objective: To observe the serum levels of amyloid protein A( SAA) and C-reactive protein( CRP) in the patients with coronary heart disease( CHD) combined with diabetes mellitus( DM). Methods: A total of 100 CHD patients confirmed by coronary heart angiography( CAG) were enrolled in this study,among which 42 patients were combined with DM( group A) and 58 patients were purely suffered from CHD( group B). The double antibody sandwich ELISA and rate nephelometry were used to detect the serum levels of SAA and CRP. The correlation of serum levels of SAA and CRP with coronary Gensini scores was analyzed. Results: The level of SAA in group A was significantly higher than that in group B and control group( P < 0. 05). The CRP level in groups A and B was significantly higher than that in the control group( P < 0. 05). The difference of CRP level between groups A and B was not statistically significant( P > 0. 05). SAA and CRP levels were positively correlated with Gensini scale( r = 0. 738,P < 0. 05),and SAA level was positively correlated with and CRP level( r = 0. 815,P < 0. 05). Conclusions: SAA and CRP levels can finely predicate the condition and prognosis of CHD combined with DM.

关键词(KeyWords)： 冠心病;糖尿病;血清淀粉样蛋白A;C反应蛋白;冠状动脉Gensini评分
coronary heart disease;diabetes mellitus;serum amyloid A;C-reactive protein;coronary antery Gensini scores

Abstract:

Keywords:

基金项目(Foundation): 河北钢铁集团科学技术项目,编号:2010GT320-03

作者(Author): 何建媚
HE Jianmei

DOI: 10.19367/j.cnki.1000-2707.2015.06.025

参考文献(References)：

• [1]陈锦峰,徐新,马绍椿,等.急性冠脉综合征患者LPPLA2与MMP-9血浆水平及临床意义[J].广东医学,2011(10):1263-1266.
• [2]王艳霞,马颖艳,刘亚斌,等.冠心病合并2型糖尿病的冠脉病变特征及危险因素分析[J].现代生物医学进展,2013(10):2293-2295.
• [3]朱雁洲,陈良龙,罗育坤,等.脂蛋白相关磷脂酶A2与血管内超声虚拟组织学斑块特征的关系及临床意义[J].临床心血管病杂志,2010(4):287-290.
• [4]曹刚,张伟霞.四种新型因子与冠心病关系的研究进展[J].医学与哲学,2013(6):47-49.
• [5]张英,覃数,张冬颖,等.超敏C反应蛋白与冠心病患者的冠状动脉病变程度及预后的关系,2012(23):45-49.
• [6]Alam I,Lewis K,Stephens JW,et al.Obesity,metabolic syndrome and sleep apnoea:all pro-inflammatory states[J].Obes Rev,2007(2):119-127.
• [7]邬建民,张力.脂蛋白相关磷脂酶A2在冠心病患者严重程度评估中的应用[J].检验医学,2011(2):85-87.
• [8]Zhang XL,Yin KS,Wang H,et al.Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome[J].Respiration,2006(73):73-77.
• [9]赵洁,吴俊,贾玫,等.冠心病患者血液脂蛋白相关磷脂酶A2与超敏C反应蛋白及D-二聚体的相关性研究[J].中华检验医学杂志,2014(3):227-229.
• [10]欧阳新根.血浆脂蛋白磷脂酶A2水平对冠心病合并2型糖尿病患者的影响[J].中国医药科学,2014(12):198-200.
• [11]许瑾瑾,张菲斐.冠心病合并糖尿病患者血清s LR11水平变化及其与冠脉病变的关系[J].河南医学研究,2013(1):5-6.

文章评论(Comment)：